Get the Stockscreener App
61.48
1.60%
0.97
After Hours:
61.48
Centene Corp stock is traded at $61.48, with a volume of 4.90M.
It is up +1.60% in the last 24 hours and up +3.48% over the past month.
Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract.
See More
Previous Close:
$60.51
Open:
$60.68
24h Volume:
4.90M
Relative Volume:
0.81
Market Cap:
$31.04B
Revenue:
$161.73B
Net Income/Loss:
$3.07B
P/E Ratio:
10.67
EPS:
5.76
Net Cash Flow:
$245.00M
1W Performance:
+1.45%
1M Performance:
+3.48%
6M Performance:
-7.91%
1Y Performance:
-19.89%
1-Day Range:
$60.33
$62.05
1-Week Range:
$59.75
$62.05
52-Week Range:
$55.03
$81.42
Centene Corp Stock (CNC) Company Profile
Name
Centene Corp
Sector
Industry
Phone
(314) 725-4477
Address
7700 FORSYTH BLVD., ST LOUIS
Compare CNC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
61.48 | 31.04B | 161.73B | 3.07B | 245.00M | 5.76 |
|
UNH
Unitedhealth Group Inc
|
513.00 | 472.11B | 389.07B | 14.32B | 13.10B | 15.35 |
|
ELV
Elevance Health Inc
|
371.56 | 86.17B | 174.02B | 6.42B | 871.00M | 27.43 |
|
CI
Cigna Group
|
280.70 | 78.08B | 229.75B | 3.04B | 5.18B | 10.60 |
|
CVS
Cvs Health Corp
|
45.77 | 57.60B | 368.91B | 5.02B | 1.69B | 3.94 |
|
HUM
Humana Inc
|
262.47 | 31.60B | 115.01B | 1.36B | -4.34B | 11.29 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Dec-13-24 | Upgrade | UBS | Neutral → Buy |
| Dec-10-24 | Downgrade | Jefferies | Hold → Underperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Mar-21-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-20-23 | Initiated | UBS | Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-30-22 | Initiated | Argus | Buy |
| Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-28-22 | Resumed | Barclays | Overweight |
| Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Resumed | Bernstein | Outperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-07-22 | Resumed | Barclays | Overweight |
| Jan-06-22 | Resumed | JP Morgan | Overweight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
| Dec-13-21 | Reiterated | BofA Securities | Buy |
| Dec-13-21 | Reiterated | Credit Suisse | Neutral |
| Dec-13-21 | Reiterated | Mizuho | Neutral |
| Dec-13-21 | Reiterated | Oppenheimer | Outperform |
| Dec-13-21 | Reiterated | Stephens | Overweight |
| Dec-13-21 | Reiterated | Truist | Buy |
| Dec-13-21 | Reiterated | Wells Fargo | Overweight |
| Dec-13-21 | Reiterated | Wolfe Research | Outperform |
| Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-19-21 | Initiated | Wells Fargo | Overweight |
| May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-10-21 | Initiated | Mizuho | Neutral |
| Jan-21-21 | Resumed | Goldman | Neutral |
| Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-03-20 | Resumed | Evercore ISI | Outperform |
| Jan-28-20 | Reiterated | Bernstein | Outperform |
| Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| May-10-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Jul-18-18 | Resumed | Citigroup | Neutral |
| Dec-18-17 | Reiterated | Jefferies | Buy |
| Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
| Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-17 | Reiterated | Barclays | Overweight |
| Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
| Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp Stock (CNC) Latest News
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
February 14th Options Now Available For Centene (CNC) - Nasdaq
Centene Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Centene Corp. stock outperforms competitors despite losses on the day - MarketWatch
Centene Corporation (CNC): Among the Cheap Healthcare Stocks to Buy Heading Into 2025 - Insider Monkey
12 Cheap Healthcare Stocks to Buy Heading into 2025 - Insider Monkey
Will Weakness in Centene Corporation's (NYSE:CNC) Stock Prove Temporary Given Strong Fundamentals? - Yahoo Finance
Centene Corp. stock rises Tuesday, still underperforms market - MarketWatch
Hedge Fund and Insider Trading News: Chris Hohn, Seth Klarman, Warren Buffett, Third Point, Palliser Capital, Centene Corp (CNC), Salesforce Inc (CRM), and More - Insider Monkey
Vanguard pays $117M for Centene’s campus office complex - Charlotte Business Journal
Principal Financial Group Inc. Acquires 22,233 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Centene cancels in-person investor day in NYC, will be held virtually - MSN
Centene Corp. stock underperforms Friday when compared to competitors - MarketWatch
Centene (NYSE:CNC) Updates FY 2024 Earnings Guidance - MarketBeat
Franklin Resources Inc. Sells 288,044 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Centene Corp director Thomas Greco buys $1.02 million in stock - Investing.com India
Thomas Greco Acquires 17,000 Shares of Centene Corp - GuruFocus.com
Thomas Greco Acquires 17,000 Shares of Centene Co. (NYSE:CNC) Stock - MarketBeat
Centene Corp director Thomas Greco buys $1.02 million in stock By Investing.com - Investing.com South Africa
Centene (NYSE:CNC) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Centene shares gain price target boost as Baird notes potential for premium valuation with policy clarity - Investing.com
Christopher Coughlin Purchases 10,000 Shares of Centene Corp (CN - GuruFocus.com
Health Net Providing Special Assistance to Members Affected by Bird Flu Throughout California - Quantisnow
Centene director Coughlin buys $594,400 in common stock By Investing.com - Investing.com South Africa
Insider Trading Insights: Key Buys and Sells from Pulse Biosciences, Centene and More - mediahousepress
Insider Buying: Centene Co. (NYSE:CNC) Director Acquires 5,000 Shares of Stock - MarketBeat
Centene director Theodore Samuels buys $294,300 in stock By Investing.com - Investing.com Australia
Centene director Theodore Samuels buys $294,300 in stock - Investing.com India
Centene director Dallas H. James acquires $99,903 in stock By Investing.com - Investing.com Nigeria
Centene director Dallas H. James acquires $99,903 in stock - Investing.com India
Centene director Jessica Blume acquires shares worth $14,870 By Investing.com - Investing.com Australia
Centene director Coughlin buys $594,400 in common stock - Investing.com
Centene director Jessica Blume acquires shares worth $14,870 - Investing.com
Centene Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
JPMorgan Chase & Co. Reaffirms Overweight Rating for Centene (NYSE:CNC) - MarketBeat
Jefferies reiterates underperform on Centene shares on concerns By Investing.com - Investing.com South Africa
Jefferies reiterates underperform on Centene shares on concerns - Investing.com
Sanctuary Advisors LLC Acquires 9,287 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Superior HealthPlan Commemorates 25-year Anniversary by Awarding $25,000 Grant to NAMI El Paso - Quantisnow
MML Investors Services LLC Boosts Stock Position in Centene Co. (NYSE:CNC) - MarketBeat
Centene's SWOT analysis: conservative guidance fuels stock potential - Investing.com
Centene (NYSE:CNC) Trading Up 3.7% on Analyst Upgrade - MarketBeat
Stephens Issues Pessimistic Forecast for Centene (NYSE:CNC) Stock Price - MarketBeat
Barclays Increases Centene (NYSE:CNC) Price Target to $93.00 - MarketBeat
11,218 Shares in Centene Co. (NYSE:CNC) Purchased by Virtu Financial LLC - MarketBeat
Centene Target of Unusually Large Options Trading (NYSE:CNC) - MarketBeat
Centene Co. (NYSE:CNC) Shares Sold by Retirement Systems of Alabama - MarketBeat
Centene Co. (NYSE:CNC) Receives $81.31 Consensus Target Price from Brokerages - MarketBeat
Centene shares target cut, retains equal weight on long term growth - Investing.com
Centene Corp Stock (CNC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):